Financial reports
10-K
2023 FY
Annual report
21 Mar 24
10-Q
2023 Q3
Quarterly report
9 Nov 23
10-Q
2023 Q2
Quarterly report
3 Aug 23
10-Q
2023 Q1
Quarterly report
4 May 23
ARS
2022 FY
Annual report to shareholders
27 Apr 23
10-K
2022 FY
Annual report
15 Mar 23
10-Q
2022 Q3
Quarterly report
9 Nov 22
10-Q
2022 Q2
Quarterly report
1 Aug 22
10-Q
2022 Q1
Quarterly report
9 May 22
10-K
2021 FY
Annual report
18 Mar 22
Current reports
8-K
Regulation FD Disclosure
25 Apr 24
8-K
Compass Therapeutics Reports 2023 Financial Results and Provides Corporate Update
21 Mar 24
8-K
Departure of Directors or Certain Officers
9 Jan 24
8-K
Compass Therapeutics Provides Corporate Update
5 Jan 24
8-K
Compass Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
9 Nov 23
8-K
Compass Therapeutics Reports Second Quarter 2023 Financial Results and Provides Corporate Update
3 Aug 23
8-K
Submission of Matters to a Vote of Security Holders
15 Jun 23
8-K
Compass Therapeutics Reports First Quarter Financial Results and Provides Corporate Update
4 May 23
8-K
Departure of Directors or Certain Officers
24 Apr 23
8-K
Regulation FD Disclosure
10 Mar 23
Registration and prospectus
424B3
Prospectus supplement
24 Jan 23
S-3
Shelf registration
2 Dec 22
424B5
Prospectus supplement for primary offering
1 Aug 22
424B5
Prospectus supplement for primary offering
15 Dec 21
424B5
Prospectus supplement for primary offering
15 Dec 21
424B5
Prospectus supplement for primary offering
3 Nov 21
424B5
Prospectus supplement for primary offering
1 Nov 21
8-A12B
Registration of securities on exchange
1 Nov 21
S-3
Shelf registration
9 Jul 21
424B3
Prospectus supplement
30 Apr 21
Proxies
DEFA14A
Additional proxy soliciting materials
27 Apr 23
DEF 14A
Definitive proxy
27 Apr 23
DEFA14A
Additional proxy soliciting materials
18 May 22
DEF 14A
Definitive proxy
28 Apr 22
DEF 14A
Definitive proxy
29 Apr 21
SC 14F1/A
Statement regarding change in majority of directors (amended)
28 May 20
SC 14F1
Statement regarding change in majority of directors
27 May 20
Other
EFFECT
Notice of effectiveness
23 Jan 23
CORRESP
Correspondence with SEC
19 Jan 23
CORRESP
Correspondence with SEC
17 Jan 23
CORRESP
Correspondence with SEC
13 Jan 23
UPLOAD
Letter from SEC
7 Dec 22
CERT
Certification of approval for exchange listing
1 Nov 21
EFFECT
Notice of effectiveness
21 Jul 21
CORRESP
Correspondence with SEC
16 Jul 21
UPLOAD
Letter from SEC
15 Jul 21
EFFECT
Notice of effectiveness
9 Mar 21